Published in Clin Infect Dis on April 18, 2007
Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease. Cell Host Microbe (2010) 3.33
Analytical and clinical performance of the CDC real time RT-PCR assay for detection and typing of dengue virus. PLoS Negl Trop Dis (2013) 2.51
The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1. PLoS Pathog (2010) 2.03
Kinetics of viremia and NS1 antigenemia are shaped by immune status and virus serotype in adults with dengue. PLoS Negl Trop Dis (2011) 1.67
Genotype-specific neutralization and protection by antibodies against dengue virus type 3. J Virol (2010) 1.58
Humanized mice show clinical signs of dengue fever according to infecting virus genotype. J Virol (2009) 1.57
Superior infectivity for mosquito vectors contributes to competitive displacement among strains of dengue virus. BMC Ecol (2008) 1.41
Endurance, refuge, and reemergence of dengue virus type 2, Puerto Rico, 1986-2007. Emerg Infect Dis (2011) 1.28
Virus-specific differences in rates of disease during the 2010 Dengue epidemic in Puerto Rico. PLoS Negl Trop Dis (2013) 1.23
Clinical and virological study of dengue cases and the members of their households: the multinational DENFRAME Project. PLoS Negl Trop Dis (2012) 1.17
Dengue virus virulence and transmission determinants. Curr Top Microbiol Immunol (2010) 1.15
Meta-analysis of all immune epitope data in the Flavivirus genus: inventory of current immune epitope data status in the context of virus immunity and immunopathology. Viral Immunol (2010) 1.14
Dengue: where are we today? Malays J Med Sci (2009) 1.10
Phylogenetic analysis of dengue virus types 1 and 4 circulating in Puerto Rico and Key West, Florida, during 2010 epidemics. Am J Trop Med Hyg (2012) 1.07
Climate Change Influences Potential Distribution of Infected Aedes aegypti Co-Occurrence with Dengue Epidemics Risk Areas in Tanzania. PLoS One (2016) 1.07
Texas and Mexico: sharing a legacy of poverty and neglected tropical diseases. PLoS Negl Trop Dis (2012) 1.04
Space-time analysis of hospitalised dengue patients in rural Thailand reveals important temporal intervals in the pattern of dengue virus transmission. Trop Med Int Health (2012) 1.04
Phylogenetic history demonstrates two different lineages of dengue type 1 virus in Colombia. Virol J (2010) 1.03
Understanding the dengue viruses and progress towards their control. Biomed Res Int (2013) 1.02
Molecular detection and typing of dengue viruses from archived tissues of fatal cases by rt-PCR and sequencing: diagnostic and epidemiologic implications. Am J Trop Med Hyg (2012) 1.02
The complexity of antibody-dependent enhancement of dengue virus infection. Viruses (2010) 0.99
Return of epidemic dengue in the United States: implications for the public health practitioner. Public Health Rep (2012) 0.92
Novel benzoxazole inhibitor of dengue virus replication that targets the NS3 helicase. Antimicrob Agents Chemother (2013) 0.91
Difference between the abilities of human Fcgamma receptor-expressing CV-1 cells to neutralize American and Asian genotypes of dengue virus 2. Clin Vaccine Immunol (2008) 0.88
Intrinsic features of Aedes aegypti genes affect transcriptional responsiveness of mosquito genes to dengue virus infection. Infect Genet Evol (2012) 0.88
PCP consensus sequences of flaviviruses: correlating variance with vector competence and disease phenotype. J Mol Biol (2009) 0.88
Twenty years of DENV-2 activity in Brazil: molecular characterization and phylogeny of strains isolated from 1990 to 2010. PLoS Negl Trop Dis (2013) 0.87
Influence of mosquito genotype on transcriptional response to dengue virus infection. Funct Integr Genomics (2014) 0.86
Nucleotide substitutions in dengue virus serotypes from Asian and American countries: insights into intracodon recombination and purifying selection. BMC Microbiol (2013) 0.86
Lineage shift in Indian strains of Dengue virus serotype-3 (Genotype III), evidenced by detection of lineage IV strains in clinical cases from Kerala. Virol J (2013) 0.85
Virological surveillance of dengue in Saint Martin and Saint Barthelemy, French West Indies, using blood samples on filter paper. Am J Trop Med Hyg (2012) 0.83
Role of complement in dengue virus infection: protection or pathogenesis? MBio (2012) 0.83
Antibodies induced by dengue virus type 1 and 2 envelope domain III recombinant proteins in monkeys neutralize strains with different genotypes. Clin Vaccine Immunol (2009) 0.82
Emergence of dengue in tribal villages of Mandla district, Madhya Pradesh, India. Indian J Med Res (2015) 0.80
Simplifying complex sequence information: a PCP-consensus protein binds antibodies against all four Dengue serotypes. Vaccine (2012) 0.79
Rise and fall of vector infectivity during sequential strain displacements by mosquito-borne dengue virus. J Evol Biol (2016) 0.76
Full-length infectious clone of a low passage dengue virus serotype 2 from Brazil. Mem Inst Oswaldo Cruz (2015) 0.75
Increasing virulence, but not infectivity, associated with serially emergent virus strains of a fish rhabdovirus. Virus Evol (2016) 0.75
Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis (2000) 11.44
Human skin Langerhans cells are targets of dengue virus infection. Nat Med (2000) 5.74
Neutralization and antibody-dependent enhancement of dengue viruses. Adv Virus Res (2003) 4.90
Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. Virology (1997) 4.88
DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J Exp Med (2003) 4.69
Molecular evolution and distribution of dengue viruses type 1 and 2 in nature. Virology (1990) 4.65
Emergence and global spread of a dengue serotype 3, subtype III virus. Emerg Infect Dis (2003) 4.29
Failure of secondary infection with American genotype dengue 2 to cause dengue haemorrhagic fever. Lancet (1999) 3.97
Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. J Infect Dis (2004) 3.81
Dengue fever, Hawaii, 2001-2002. Emerg Infect Dis (2005) 3.62
Microevolution and virulence of dengue viruses. Adv Virus Res (2003) 3.41
Epidemiologic, clinical, and virologic observations on dengue in the Kingdom of Tonga. Am J Trop Med Hyg (1978) 3.08
Murine model for dengue virus-induced lethal disease with increased vascular permeability. J Virol (2006) 3.07
Ecological and immunological determinants of dengue epidemics. Proc Natl Acad Sci U S A (2006) 2.92
Cross-protective immunity can account for the alternating epidemic pattern of dengue virus serotypes circulating in Bangkok. Proc Natl Acad Sci U S A (2006) 2.77
Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis. J Virol (2006) 2.76
Immunopathological mechanisms in dengue and dengue hemorrhagic fever. Curr Opin Infect Dis (2006) 2.52
Selection for virulent dengue viruses occurs in humans and mosquitoes. J Virol (2005) 2.50
The Emperor's New Clothes revisited, or reflections on the pathogenesis of dengue hemorrhagic fever. Am J Trop Med Hyg (1977) 2.41
Epidemiology of dengue in Sri Lanka before and after the emergence of epidemic dengue hemorrhagic fever. Am J Trop Med Hyg (2002) 2.26
Aedes aegypti vectorial capacity is determined by the infecting genotype of dengue virus. Am J Trop Med Hyg (2006) 2.07
American genotype structures decrease dengue virus output from human monocytes and dendritic cells. J Virol (2003) 2.03
Dynamic effects of antibody-dependent enhancement on the fitness of viruses. Proc Natl Acad Sci U S A (2005) 2.02
Prospective study of the duration and magnitude of viraemia in children hospitalised during the 1996-1997 dengue-2 outbreak in French Polynesia. J Med Virol (2000) 2.02
Slower rates of clearance of viral load and virus-containing immune complexes in patients with dengue hemorrhagic fever. Clin Infect Dis (2006) 1.99
Pandemic dengue in Caribbean countries and the southern United States--past, present and potential problems. N Engl J Med (1971) 1.98
Human dendritic cells as targets of dengue virus infection. J Investig Dermatol Symp Proc (2001) 1.96
Dengue fever in humanized NOD/SCID mice. J Virol (2005) 1.96
The future of dengue vaccines. Lancet (2002) 1.90
Race: a risk factor for dengue hemorrhagic fever. Arch Virol (2006) 1.84
Cities spawn epidemic dengue viruses. Nat Med (2004) 1.54
Dengue virus circulation and evolution in Mexico: a phylogenetic perspective. Arch Med Res (2006) 1.38
Differential enhancement of dengue virus immune complex infectivity mediated by signaling-competent and signaling-incompetent human Fcgamma RIA (CD64) or FcgammaRIIA (CD32). J Virol (2006) 1.34
Models of dengue virus infection. Drug Discov Today Dis Models (2006) 1.18
Classical dengue hemorrhagic fever resulting from two dengue infections spaced 20 years or more apart: Havana, Dengue 3 epidemic, 2001-2002. Int J Infect Dis (2005) 1.17
Underdiagnosis of dengue--Laredo, Texas, 1999. MMWR Morb Mortal Wkly Rep (2001) 1.16
Natural selection for rash-forming genotypes of the varicella-zoster vaccine virus detected within immunized human hosts. Proc Natl Acad Sci U S A (2006) 1.09
A dominant role for FcgammaRII in antibody-enhanced dengue virus infection of human mast cells and associated CCL5 release. J Leukoc Biol (2006) 0.95
Travel-associated dengue--United States, 2005. MMWR Morb Mortal Wkly Rep (2006) 0.92
CD40 ligand enhances dengue viral infection of dendritic cells: a possible mechanism for T cell-mediated immunopathology. J Immunol (2006) 0.91
Genetic diversity of hepatitis B virus as an important factor associated with differences in clinical outcomes. J Infect Dis (2006) 0.91
Dengue and South Texas: information for clinicians. Tex Med (2006) 0.78